Global Radiotherapy Market, 2018-2023 - ResearchAndMarkets.com

DUBLIN--()--The "Global Radiotherapy Market - Segmented by Type, Application, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The Radiotherapy Market is expected to witness a CAGR of 6.9% during the forecast period (2018-2023). The Radiotherapy Market was worth USD 7197.57 million in 2017 and is expected to display a promising upward growth in the next 5 years.

Over the years, it has been observed that the cost of radiotherapy treatment has decreased substantially. The reduced cost of the cancer treatment can be attributed to the insurance coverage, and the cost varies from region to region. The average cost for a course of radiotherapy per patient was USD 8,600 for breast cancer, USD 9,000 for lung cancer, and USD 18,000 for prostate cancer.

However, out-of-pocket expenses are about USD 10,000 to USD 50,000 or more, depending on the type of cancer and the number of sessions required. Therefore, along with favorable healthcare policies, the average cost of cancer treatment is expected to reduce during the forecast period, driving the cancer-affected population to consider opting for low range cost-effective treatment methods, like radiotherapy. In turn, this trend is expected drive the growth of the global market during the forecast period.

Other factors driving the radiotherapy market include, technological advancements in radiotherapy products, rise in number of geriatric population, lucrative reimbursement plans, and huge government and non-government investments in the R&D of cancer treatment.

Key Developments in the Market

  • November 2017: Toshiba Medical launched New MR Solution to enhance Oncology Radiation Therapy. They have introduced the Galan RT Solutions suite of radiation therapy tools. Galan RT Solutions allows healthcare providers to precisely map the MR data to PET/CT images to develop confident plans for radiation therapy and prioritize exceptional patient care.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • GE Healthcare
  • Siemens
  • Toshiba
  • IBA
  • Varian
  • Cardinal Health
  • Nordion
  • Isoray
  • RadCalc
  • Mirada Medical

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/mgm4zg/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Nuclear Medicine and Radiopharmacology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Nuclear Medicine and Radiopharmacology